Effect of Olopatadine in treatment of hand eczema

Phase 2

Recruiting

• Conditions: Investigating the effect of Olopatadine cream on hand eczema.; Other atopic dermatitis; L20.8

• Registration Number: IRCT20240614062122N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 76

Inclusion Criteria

All patients with a diagnosis of hand eczema ,(including all types of eczema in the acute phase )whose disease is confirmed by biopsy or a dermatologist's diagnosis
The age of the patients is 18 years or older
Consent to participate in the study

Exclusion Criteria

Pregnant and breastfeeding
Systemic treatment has been done in the last 3 months or local treatment 2 weeks ago
The place of use of the medicine is infectious

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The severity score of the clinical symptoms of hand eczema using the Hand Eczema Severity Index ,as well as the evaluation of the severity of itching using the Neurologic Rating Scale. Timepoint: Measuring the intensity of the clinical symptoms of hand eczema using the Hand Eczema Severity Index and itching intensity using the Neurologic Rating Scale at the beginning of the study ,then every two weeks until the end of the study (for 3 months) and 4 weeks after the end of the study. Method of measurement: Hand Eczema Severity Index Neurologic Rating Scale.